Immunotherapy Today

Immunotherapy News From Around The World

An Initiative Led by Parker Institute for Cancer Immunotherapy and Cancer Research Institute Discovers Keys That Could Unlock Better Personalized Treatments to Destroy Cancer – KPVI News 6

Posted by btwatson on October 9, 2020 3:37 pm
Tags:
Categories: Crispr Articles

Source: An Initiative Led by Parker Institute for Cancer Immunotherapy and Cancer Research Institute Discovers Keys That Could Unlock Better Personalized Treatments to Destroy Cancer – KPVI News 6

[unable to retrieve full-text content]

An Initiative Led by Parker Institute for Cancer Immunotherapy and Cancer Research Institute Discovers Keys That Could Unlock Better Personalized Treatments to Destroy Cancer  KPVI News 6
Published at Fri, 09 Oct 2020 15:03:00 +0000

< Immunotherapy Today home

Immunotherapy News

  • First-line immunotherapy shows success treating advanced colorectal cancer - Medical Xpress
    April 20, 2026
  • Enara Bio Presents First-in-Class DARKFOX-Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential in Solid Tumor Immunotherapy - The Manila Times
    April 20, 2026
  • Bowel cancer immunotherapy clinical trial follow-up shows zero relapses - Medical Xpress
    April 20, 2026
  • New bowel cancer immunotherapy treatment ‘highly effective’ in improving survival rates - The Independent
    April 20, 2026
  • In early trial, CAR-T results raise hope of preventing multiple myeloma in high-risk patients - statnews.com
    April 20, 2026
  • First Patient Dosed in JANX014 Trial in Metastatic CRPC - Targeted Oncology
    April 20, 2026
  • Trial Shows Deep and Lasting Responses to CAR-T Therapy for Smoldering Multiple Myeloma - Cancer Health
    April 20, 2026
  • Decoding the Complex Chemokine Signals in the Tumor Microenvironment to Advance Immunotherapy - Bioengineer.org
    April 20, 2026
  • PD-L1 Score for Head and Neck Cancer: What It Means - Everyday Health
    April 20, 2026
  • Understanding the diverse chemokine signals in tumor microenvironment for advanced immunotherapy - EurekAlert!
    April 20, 2026

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
  • JITC tumor and cancer immunotherapy papers collection
    JITC tumor and cancer immunotherapy papers collection
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
  • Immunotherapy shows promise for advanced lymphoma: study
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
  • Load more [+]

Copyright 2018 ImmunoTherapyToday.com